25/09/2025
“Coming up, we look at a new breakthrough in HIV prevention. Two Indian drugmakers, backed by the Gates Foundation and Unitaid, will soon roll out a twice-a-year injection called lenacapavir — costing about the same as daily HIV prevention pills already available in South Africa. With approval expected by November, could this be the game-changer in making HIV prevention simpler and more affordable?”